Stock research

INCYTE CORP (INCY) stock

Healthcare·Services-Commercial Physical & Biological Research·Market cap $26.0B
Auto-Brief · synthesised from 5 layers
INCY · us_stock
BULLISH
Confidence70%
Top reasons
  1. 1Revenue growth 20.9% YoY, net margin 26.7%.
  2. 2earnings: INCY Q2 2026 earnings reported (scheduled 2026-07-28)
  3. 3No macro events in the recency window.
Generated 7/29/2026, 10:18:15 AM · ai:classify → deterministic:news → deterministic:macro5 layers
Meaterm briefs are analytical research. Not investment advice. Not a recommendation to buy, sell, or hold any asset.

Factor grades

As of 2026-07-28
Composite
B+
77th percentile
Valuation
C
53rd percentile
Growth
A-
90th percentile
Profitability
A-
85th percentile
Momentum
B+
81st percentile

Percentile grades within the stock’s sector, computed nightly from SEC filings. Statistical ranking, not investment advice.

Fair value estimate

Current price
$129.93
Fair value estimate
$162.42
Verdict
UNDERVALUED
estimate 25.0% above price

Median of 5 peer-multiple estimates. Not investment advice.

Research INCY with the full toolkit
Charts, screeners, factor rankings, filings and positioning data in one browser-based terminal. Free tier, no card required.
Open INCY in the Meaterm terminal →
MacroNEUTRALNo feed
0 items
  • No macro events in the recency window.
No macro events in the recency window.
CatalystsBULLISHLive
1 item
  • earnings: INCY Q2 2026 earnings reported (scheduled 2026-07-28)
  1. earningsScheduled 2026-07-28
    INCY Q2 2026 earnings reported
    Reported EPS 3.09 vs. estimate 2.14.
    BULLISH
FundamentalsBULLISHLive
1 item
  • Revenue growth 20.9% YoY, net margin 26.7%.
  • Forward P/E 14.586764, FCF $0.6B.
  • Earnings beat 0% of trailing 0 quarters.
Revenue growth (YoY)
20.9%
>10% strong
Net margin
26.7%
>15% healthy
Debt / Equity
0.70
<1 conservative
Interest coverage
0.0×
>3 safe
Beta
0.76
vs. SPX
Forward P/E
14.6
Free cash flow
$558.9M
TTM
Earnings beat rate
0%
Trailing 0 quarters
As of 2026-07-29 · Issuer filings + market data
PositioningNEUTRALLive
0 items
Top 13F holders
  • Baker Bros. Advisors, LP30.7M sh · +0.00% QoQ
  • Blackrock Inc.19.0M sh · +3.55% QoQ
  • Dodge & Cox Inc.12.3M sh · -7.61% QoQ
  • Vanguard Capital Management LLC10.9M sh · +100.00% QoQ
  • State Street Corporation9.6M sh · -0.16% QoQ
As of 2026-06-30 · Meaterm
NewsNEUTRALNo feed
0 items
  • No news in the recency window.
  • Signal steady (bullish) vs the last brief.
No news in the recency window.

Key fundamentals

Revenue (TTM)
$5.4B
Net income (TTM)
$1.4B
Diluted EPS (TTM)
$7.08
Gross margin
Operating margin
30.0%
Net margin
26.7%

Trailing-twelve-month figures computed by Meaterm from SEC filings, refreshed nightly.

Related Services-Commercial Physical & Biological Research stocks

Frequently asked questions

What are the INCY factor grades?

Meaterm scores INCYTE CORP (INCY) on four factors — valuation, growth, profitability and momentum — plus a composite. Each grade is a percentile ranking against the stock's sector, computed nightly from SEC-filed financial data. Grades are statistical rankings, not investment advice or a recommendation to trade.

How is the fair value estimate for INCY calculated?

The estimate is the median of several peer-multiple implied values — peer P/E, EV/EBITDA, P/S and P/B applied to the company's own fundamentals — plus a sell-side consensus target when one is available. Peers come from the same industry, matched by size. It is a statistical reference point, not a price target and not investment advice.

Where does the data on this page come from?

Fundamentals and factor grades are computed by Meaterm from SEC filings and refreshed nightly. Positioning context comes from public CFTC and FINRA releases, and macro series from FRED. Every signal, grade and estimate shown is Meaterm’s own computation.

Is INCY a good stock to invest in?

Meaterm does not answer that question. This page shows how INCYTE CORP (INCY) ranks statistically against sector peers on valuation, growth, profitability and momentum, and where its price sits relative to a peer-multiple estimate. Use it as research context alongside your own analysis — nothing on this page is investment advice.

How often is this page updated?

Factor grades, fundamentals and the company profile refresh nightly after each trading day. The brief layers — macro, catalysts, positioning and news — are composed when the page loads, and the fair value estimate is recomputed with recent quotes during the day.

Termi
Meaterm Support · Online
Hi, I'm Termi 👋 — Meaterm's AI assistant, not a human. I can help you navigate the platform, explain features, and answer questions about plans, supported markets, and your account. I may make mistakes, so please verify anything important before relying on it. I can't give investment, tax, or legal advice. How can I help?
AI-assisted support · For account issues, email support@meaterm.com